Paper Details

  1. Home
  2. Paper Details

Risk of Retention After OnabotulinumtoxinA Injection for Overactive Bladder in a Diverse Urban Population With High BMI and Comorbidity Rates.

Author: Aalami HarandiArshia, AbrahamNitya E, NauheimJennifer

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Patients with high baseline postvoid residual volume (PVR) (100 + mL) should be counseled regarding a potentially higher risk of postoperative urinary retention (POUR) after onabotulinumtoxinA (BTX-A) injection for overactive bladder (OAB). This retrospective review of 185 patients showed that patients with preoperative PVR 100+ mL had nearly 4-fold higher odds of POUR compared with patients with PVR less than 50 mL.
Paper Details　
Original Abstract of the Article :
IMPORTANCE: OnabotulinumtoxinA (BTX-A) injection is a third-line therapy for overactive bladder (OAB). Patients undergoing treatment have a 6.5% chance of requiring clean intermittent catheterization (CIC) due to postoperative urinary retention (POUR). OBJECTIVE: The aim of this study was to evalua...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/36548104

データ提供：米国国立医学図書館（NLM）

Risk of Retention After OnabotulinumtoxinA Injection for Overactive Bladder

This research explores the realm of urology, focusing on the treatment of overactive bladder (OAB) with onabotulinumtoxinA (BTX-A) injections. The authors investigated the risk factors for urinary retention after BTX-A injections, a complication that can lead to the need for clean intermittent catheterization (CIC). It's like a camel caravan facing a challenging desert crossing, where navigating potential obstacles is crucial for a successful journey.

Exploring the Risks and Benefits of BTX-A

The study found that while high BMI is not associated with an increased risk of urinary retention after BTX-A injection, patients with high baseline postvoid residual volume (PVR) (over 100 mL) are at a higher risk. This finding has important implications for patient counseling and shared decision-making. It's like a camel caravan choosing a route based on the terrain and avoiding areas known to be prone to sandstorms.

Informed Decision-Making in Urology

This research highlights the importance of informed decision-making in urology, especially when considering BTX-A injections for OAB. It's crucial to discuss the potential risks and benefits of treatment with patients, taking into account factors such as their baseline PVR. It's like a camel caravan making careful preparations before embarking on a long desert journey, ensuring the safety and well-being of all participants.

Dr. Camel's Conclusion

This research provides valuable information for patients and physicians considering BTX-A treatment for OAB. By understanding the potential risks and benefits, patients can make informed decisions about their treatment and improve their chances of a successful outcome. This is like a camel caravan approaching a new oasis, navigating the landscape with knowledge and preparation to ensure a safe and rewarding journey.

Date :
  1. Date Completed 2022-12-26
  2. Date Revised 2023-03-09
Further Info :

Pubmed ID

36548104

DOI: Digital Object Identifier

02273501-202301000-00005

Related Literature

Article Analysis
・Effects of onabotulinumtoxina injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.